RecruitingEarly Phase 1NCT04274998

Neuroinflammation Imaging in AD

Evaluation of in Vivo Neuroinflammation in Alzheimer's Disease Using Novel Positron Emission Tomography (PET/CT) Imaging


Sponsor

University of Pennsylvania

Enrollment

20 participants

Start Date

Mar 3, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This research study is being done to learn more about inflammation in the brain using Positron Emission Tomography/Computed Tomography (PET/CT) imaging in people with Alzheimer's Disease/Mild Cognitive Impairment or healthy controls. If the subject agrees to be in this study, she/ he will have a PET/CT scan using the investigational radiotracer \[18F\]NOS. A subject with a specific genetic polymorphism may also agree to be in the sub-study in which she/he will have another PET/CT scan using the investigational tracer \[11C\]PBR28 for comparison with the FNOS \[18F\]NOS scan. For subjects who agree to this sub-study they may undergo the brain PET/CT scan with \[11C\]PBR28 either on the same day as the \[18F\]NOS PET/CT or on another day. The subject may have a screening visit before the PET/CT scan visit if the investigator needs to confirm the subject is able to be in the study. A blood sample will be taken before the scans. Additional blood samples will be taken during the PET scans. Subjects must also agree to have an MRI scan for this research study if she/he has not had a recent scan that the study doctor decides can be used for this study.


Eligibility

Min Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study looks at brain inflammation in people with Alzheimer's disease and in healthy older adults. Researchers use special brain scans to measure inflammation and see whether it is linked to memory and thinking problems. This helps scientists understand how Alzheimer's develops. **You may be eligible if...** - You are 55 or older - You are part of an existing Alzheimer's research program at the University of Pennsylvania - You have had a brain amyloid scan within the past year that came back negative (for the healthy volunteer group) - Your memory and thinking tests are in the normal range (MMSE score of 28 or higher) **You may NOT be eligible if...** - You have a positive amyloid scan - Your thinking scores are below the normal range - You are unwilling or unable to provide written consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG[18F]NOS

Main Study: PET/CT imaging will be used to evaluate neuroinflammation in the brain using the investigational radiotracer \[18F\]NOS.

DRUG[11C]PBR28

Sub-Study: Additional PET/CT imaging will be used to evaluate neuroinflammation in the brain for subjects with specific genetic polymorphism using the investigational radiotracer \[11C\]PBR28 in comparison to \[18F\]NOS.


Locations(1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04274998


Related Trials